1887

Abstract

The Genie HIV-1/2 kit (Sanofi Diagnostics Pasteur, Montreal, Quebec), a synthetic-peptide solid-phase enzyme immunoassay, was evaluated as a confirmatory assay for HIV-1 antibodies in comparison with Western blot (BioRad, Hercules, CA, USA) on 50 stored HIV-1 antibody-positive sera and the 137 sera yielding repeated positive results in the conventional EIA screen out of 13405 fresh patient sera from Saskatchewan in 1993. The stored HIV-1-positive sera were uniformly positive in the Genie test. Of the 137 EIA screen-positive sera, 33 were uniformly positive and 64 were uniformly negative in Genie and Western blot; 36 were Genie-negative and indeterminate by Western blot; and four were Genie indeterminate, of which one was negative and three were indeterminate by Western blot. All HIV-1 Western blot-indeterminate and Genie-indeterminate sera were negative in radio-immunoprecipitation assay (RIPA) and Western blot for HIV-1 and HIV-2 antibodies performed by a reference laboratory. Genie gave an accurate definitive result for 97% of EIA positive sera compared with 71% for Western blot. There was excellent correlation between Genie, Western blot and RIPA results. However, the Genie assay was faster, less costly and yielded fewer indeterminate results than Western blot in confirmatory testing for HIV-1 antibodies.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-44-3-223
1996-03-01
2024-04-18
Loading full text...

Full text loading...

/deliver/fulltext/jmm/44/3/medmicro-44-3-223.html?itemId=/content/journal/jmm/10.1099/00222615-44-3-223&mimeType=html&fmt=ahah

References

  1. Anon Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections. MMWR 1989; 38: Suppl 71–6
    [Google Scholar]
  2. Wang J. J. G., Steel S., Wisniewolski R., Wang C. Y. Detection of antibodies to human T-lymphotropic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp41 envelope protein. Proc Natl Acad Sci USA 1986; 83:6159–4063
    [Google Scholar]
  3. Gnann J. W., McCormick J. B., Mitchell S., Nelson J. A., Oldstone M. B. A. Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections. Science 1987; 237:1346–1349
    [Google Scholar]
  4. Valkirs G. E., Barton R. Immunoconcentration — a new format for solid-phase immunoassays. Clin Chent 1985; 31:1427–1431
    [Google Scholar]
  5. Midthun K., Garrison L., Clements M. L. Frequency of indeterminate Western blot tests in healthy adults at low risk for human immunodeficiency virus infection. J Infect Dis 1990; 162:1379–1382
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-44-3-223
Loading
/content/journal/jmm/10.1099/00222615-44-3-223
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error